Citation Impact
Citing Papers
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
2003 Standout
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas
2006
Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy.
2000
The significance of cagA + Helicobacter pylori in reflux oesophagitis
2001
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin
2002
Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer
2004
Population pharmacokinetics in phase I drug development: a phase I study of PK1 in patients with solid tumours
1999
Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT)
2004
Poly(amidoamine)s as Potential Endosomolytic Polymers: EvaluationIn Vitroand Body Distribution in Normal and Tumour-Bearing Animals
1999
Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor
1994
Dendrimers:
2000
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
Protein‐Based Nanomedicine Platforms for Drug Delivery
2009
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
2004
HPMA Copolymers Platinates Containing Dicarboxylato Ligands. Preparation, Characterisation and In Vitro and In Vivo Evaluation
2002
A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours
2004
PDEPT: polymer-directed enzyme prodrug therapy
2001
Polymer-drug conjugates: Recent development in clinical oncology
2008
Prodrug Strategies in Anticancer Chemotherapy
2007
Rationally Designed Chemical Modulators Convert a Bacterial Channel Protein into a pH‐Sensory Valve
2006 StandoutNobel
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Rhabdomyolysis and Acute Kidney Injury
2009 Standout
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting
2001 Standout
Esophageal Cancer
2003 Standout
Polymeric anticancer drugs with pH-controlled activation
2004
Fluorescence intensity and lifetime imaging of free and micellar-encapsulated doxorubicin in living cells
2008
Nanotheranostics ˗ Application and Further Development of Nanomedicine Strategies for Advanced Theranostics
2014
HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action
2000
A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
2014 StandoutNobel
Polymer conjugates as anticancer nanomedicines
2006 Standout
Helicobacter pylori: microbiology of a ‘slow’ bacterial infection
1993
Polymer Therapeutics: Concepts and Applications
2006
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
Polymer Therapeutics Designed for a Combination Therapy of Hormone‐Dependent Cancer
2005
Phase I Study of CT-2103, A Polymer-Conjugated Paclitaxel, and Carboplatin in Patients with Advanced Solid Tumors
2005
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease
1995
Progress of drug-loaded polymeric micelles into clinical studies
2014
Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applications
2012
Symptomatic Benefit from EradicatingHelicobacter pyloriInfection in Patients with Nonulcer Dyspepsia
1998
Polymer-Based Cancer Nanotheranostics: Retrospectives of Multi-Functionalities and Pharmacokinetics
2013
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
HPMA copolymers: Origins, early developments, present, and future☆
2009
Novel photosensitizer-protein nanoparticles for Photodynamic therapy: Photophysical characterization and in vitro investigations
2009
Application of Nanotechnology in Cancer Therapy and Imaging
2008
Advanced materials and processing for drug delivery: The past and the future
2012
HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo
1999
Polymer–drug conjugates: towards a novel approach for the treatment of endrocine-related cancer
2005
Helicobacter pyloriInfection
2002 Standout
Design strategies to improve soluble macromolecular delivery constructs
2003
Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt
2009
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
2000 Standout
Organic Switches for Surfaces and Devices
2012 StandoutNobel
Poly-(L)-Glutamic Acid-Paclitaxel (CT-2103) [XYOTAX™], a Biodegradable Polymeric Drug Conjugate
2004
Polymer–drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic
2001
The dawning era of polymer therapeutics
2003 Standout
Water soluble polymers in tumor targeted delivery
2001
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
Polyester Dendritic Systems for Drug Delivery Applications: Design, Synthesis, and Characterization
2002
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
2006
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
Enhancement of the Cytotoxicity and Selectivity of Doxorubicin to Hepatoma Cells by Synergistic Combination of Galactose-Decorated γ-Poly(glutamic acid) Nanoparticles and Low-Intensity Ultrasound
2014
Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data
2003
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Intracellular Delivery of a Proapoptotic Peptide via Conjugation to a RAFT Synthesized Endosomolytic Polymer
2009
Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymerdoxorubicin (PK1)
1998
Nonviral Vectors for Gene Delivery
2008 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Tumour vasculature as a target for anticancer therapy
2000
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Recent Developments in the Preparation and Chemistry of Metallacycles and Metallacages via Coordination
2015 Standout
Three-dimensional cell cultures: from molecular mechanisms to clinical applications
1997
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Gadolinium-Based Hybrid Nanoparticles as a Positive MR Contrast Agent
2006
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
2002
Designing polymer conjugates as lysosomotropic nanomedicines
2007
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
2011 Standout
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Sequential activation and lethal hit measured by [Ca2+]i in individual cytolytic T cells and targets.
1987 StandoutNobel
Enzyme-Responsive Snap-Top Covered Silica Nanocontainers
2008 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The Chemistry of Neutron Capture Therapy
1998 Standout
Helicobacter pylori Adhesin Binding Fucosylated Histo-Blood Group Antigens Revealed by Retagging
1998 StandoutScience
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Synthesis and Characterization of AP5346, a Novel Polymer-Linked Diaminocyclohexyl Platinum Chemotherapeutic Agent
2006
Thermogelling Polymer–Platinum(IV) Conjugates for Long-Term Delivery of Cisplatin
2014
MITOCHONDRIAL CALCIUM OVERLOAD: A GENERAL MECHANISM FOR CELL-NECROSIS IN MUSCLE DISEASES
1976
Polyester Dendritic Systems for Drug Delivery Applications: In Vitro and In Vivo Evaluation
2002
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
2009 StandoutNobel
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
2016
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Emerging Droplet Microfluidics
2017 Standout
Clinical Translation of Nanomedicine
2015
HPMA copolymer–aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines
2005
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Works of T. E. Hilditch being referenced
Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer
1998
Strategies for systemic radiotherapy of micrometastases using antibody-targeted 131I
1988
Plasma Gastrin, Daytime Intragastric pH, and Nocturnal Acid Output before and at 1 and 7 Months after Eradication ofHelicobacter pyloriin Duodenal Ulcer Subjects
1991
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.
1999
Studies on the carrier state in X-linked recessive (Duchenne) muscular dystrophy
1975
Tumor spheroid model for the biologically targeted radiotherapy of neuroblastoma micrometastases.
1990